Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- "Clinical Trial Services Market by Type (Laboratory, Monitoring, Recruitment, PV, Data Management), Phase (I, II, III), Therapy (Oncology, Neurology,...
-
Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- "Clinical Trial Supplies Market by Services (Manufacturing, Sourcing, Packaging, Labelling, Logistics), Phases, Type (Small Molecules, Biologics,...
-
Dublin, April 15, 2025 (GLOBE NEWSWIRE) -- The "Central Lab Services/Clinical Trial Lab Services Market by Phase (Phase I, II, III), Service Type (Safety Testing, Immunology), Therapeutic Area...
-
Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trials Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
-
– Clinically Meaningful Efficacy Observed on Multiple Assessments – – Confirmed Target Engagement with Reduced Iron Signal in MSA Affected Brain Regions – MELBOURNE, Australia and SAN FRANCISCO,...
-
Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "LAG-3 Targeting Therapy Market, Drug Dosage, Patent, Sales & Clinical Trials Insight 2030 Report" report has been added to ...
-
Science 37 announces the successful completion of its second FDA inspection, reaffirming the quality of its Direct-to-Patient Site for clinical research.
-
Salt Lake City, UT, April 08, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that the first...
-
MOUNTAIN VIEW, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Egnyte, a leader in cloud content security and compliance, will host its Life Sciences Summit 2025 on April 16 at 12:00 PM Eastern. The...
-
Dublin, April 07, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trial Monitoring Training Course" has been added to ResearchAndMarkets.com's offering. With regulatory inspectors increasingly finding GCP...